Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: Study protocol for a randomized controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Cuypers, Maarten ^a   Lamers, Romy E D ^b   Kil, Paul J M ^b   van de Poll Franse, Lonneke V ^a,c   de Vries, Marieke ^a,d  

^a TILBURG UNIVERSITY   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c The Netherlands   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

Author keywords

decision aid; decisional conflict; decisional regret; implementation; information provision; Prostate cancer; shared decision making; treatment choice; values clarification methods

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; COMPUTER PROGRAM; CONSULTATION; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DOCTOR PATIENT RELATION; EARLY CANCER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METHODOLOGY; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT INFORMATION; PATIENT PREFERENCE; PATIENT SATISFACTION; PROSTATE CANCER; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHARED DECISION MAKING; VALUES CLARIFICATION METHOD; WEB BASED TREATMENT DECISION AID; CANCER STAGING; COMPUTER ASSISTED THERAPY; CONFLICT; DECISION MAKING; EMOTION; INTERNET; PATIENT PARTICIPATION; PATIENT REFERRAL; PATIENT SELECTION; PREDICTIVE VALUE; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

CHOICE BEHAVIOR; CLINICAL PROTOCOLS; CONFLICT (PSYCHOLOGY); DECISION SUPPORT TECHNIQUES; EMOTIONS; HUMANS; INTERNET; MALE; NEOPLASM STAGING; NETHERLANDS; PATIENT PARTICIPATION; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; RESEARCH DESIGN; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84934980180     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0750-x     Document Type: Article

References (68)

1. Netherlands Cancer Registry. Cijfers over kanker [internet]. Utrecht: Comprehensive Cancer Centre The Netherlands; 2014. http://www.cijfersoverkanker.nl Accessed 1 October 2014.
2. Post P, Kil P, Crommelin M, Schapers R, Coebergh J-W. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995. Eur J Cancer. 1998;34:705-9.
3. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366:981-90.
4. Dutch Cancer Society. Kwaliteit van kankerzorg in Nederland: voortgang en blik op de toekomst. Amsterdam: KWF Kankerbestrijding; 2014.
5. National Institute for Public Health and the Environment. Volksgezondheid Toekomst Verkenning. In: Nationaal Kompas Volksgezondheid [internet]. Bilthoven: RIVM; 2014. https://www.volksgezondheidenzorg.info/onderwerp/prostaatkanker Accessed 1 October 2014.
6. Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007;100:544-51.
7. Van den Bergh RC, Korfage IJ, Bangma CH. Psychological aspects of active surveillance. Curr Opin Urol. 2012;22:237-42.
8. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124-37.
9. Kramer KM, Bennett CL, Pickard AS, Lyonsn EA, Wolf MS, McKoy JM, et al. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. 2005;4:15-23.
10. Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, et al. Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician? Cancer. 2013;119:421-8.
11. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer. 2001;84:48.
12. Hoffmann TC, Légaré F, Simmons MB, McNamara K, McCaffery K, Trevena LJ, et al. Shared decision making: What do clinicians need to know and why should they bother? Med J Aust. 2014;201:35-9.
13. Degner LF, Davison BJ, Sloan JA, Mueller B. Development of a scale to measure information needs in cancer care. J Nurs Meas. 1998;6:137-53.
14. Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol. 2013;189:S59-65.
15. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012;30:1160-77.
16. O'Connor AM, Llewellyn-Thomas HA, Flood AB. Modifying unwarranted variations in health care: shared decision making using patient decision aids. Health Aff. 2004;2004:63-72.
17. Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ. 2002;325:961.
18. Vektis. Rapportage indicatoren indicatiestelling (praktijkvariatie). Zeist: Vektis; 2011.
19. Comprehensive Cancer Center South. Factsheet prostate cancer. Eindhoven: IKZ; 2012.
20. Healthcare Insurance Board. Robotprostaatchirurgie: Vanzelfsprekend? Diemen: CVZ; 2011.
21. Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009;59:379-90. doi:10.3322/caac.20039.
22. Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, et al. Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin. 2015;65(3):239-51.
23. Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacioglu U, Gawkowska-Suwinska M, et al. Information for decision making by patients with early-stage prostate cancer a comparison across 9 countries. Med Decis Making. 2011;31:754-66.
24. Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J, et al. The impact of explicit values clarification exercises in a patient decision Aid emerges after the decision is actually made evidence from a randomized controlled trial. Med Decis Making. 2012;32:616-26.
25. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aid: online international Delphi consensus process. BMJ. 2006;333:417-9.
26. Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;336:876-80.
27. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:1-8.
28. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328:702-8.
29. Schellings R, Kessels A, Sturmans F. Prerandomisatie bij wetenschappelijk onderzoek: een taboe doorbroken. Ned Tijdschr Geneeskd. 2008;152:2053-6.
30. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol. 2000;57:315-21.
31. Van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47:2188-94.
32. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25-30.
33. Koedoot N, Molenaar S, Oosterveld P, Bakker P, de Graeff A, Nooy M, et al. The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns. 2001;45:187-93.
34. Feldman-Stewart D, Brundage M, Siemens R, Skarasgard D. A randomized controlled trial comparing two educational booklets on prostate cancer. Can J Urol. 2006;13:3321.
35. Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ, et al. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol. 2013;31:1012-21.
36. Hacking B, Wallace L, Scott S, Kosmala Anderson J, Belkora J, McNeill A. Testing the feasibility, acceptability and effectiveness of a 'decision navigation' intervention for early stage prostate cancer patients in Scotland-a randomised controlled trial. Psychooncology. 2013;22:1017-24.
37. Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Making. 2003;23:281-92.
38. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996;156:1414-20.
39. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O'Connor AM. Validation of a preparation for decision making scale. Patient Educ Couns. 2010;78:130-3.
40. Llewellyn CD, Horne R, McGurk M, Weinman J. Development and preliminary validation of a new measure to assess satisfaction with information among head and neck cancer patients: the satisfaction with cancer information profile (SCIP). Head Neck. 2006;28:540-8.
41. Sepucha K. Decision quality worksheet: for treating prostate cancer v.1.0. Massachusetts General Hospital. 2010. http://www.massgeneral.org/decisionsciences/research/DQ_Instrument_List.aspx Accessed 1 October 2014.
42. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
43. Van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418-24.
44. Uebersax JS, Wyman JF, Shumaker SA, McClish DK. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn. 1995;14:131-9.
45. Moore KN, Jensen L. Testing of the incontinence impact questionnaire (IIQ 7) with men after radical prostatectomy. Wound Ostomy Continence Nurs. 2000;27:304-12.
46. Bloem S, Stalpers J. Subjective Experienced Health as a Driver of Health Care Behavior. Nyenrode Research Paper Series. 2012;12:1-19.
47. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:1-265.
48. Levy H, Ubel PA, Dillard AJ, Weir DR, Fagerlin A. Health numeracy the importance of domain in assessing numeracy. Med Decis Making. 2013;34:107-15.
49. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588-94.
50. O'Connor AM. User manual-decision self-efficacy scale. Ottawa: Ottawa Hospital Research Institute (OHIR); 1995. p. 4. Available from: https://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decision_SelfEfficacy.pdf Accessed 1 October 2014.
51. Orom H, Penner LA, West BT, Downs TM, Rayford W, Underwood W. Personality predicts prostate cancer treatment decision making difficulty and satisfaction. Psychooncology. 2009;18:290-9.
52. Wong F, Stewart DE, Dancey J, Meana M, McAndrews MP, Bunston T, et al. Men with prostate cancer: influence of psychological factors on informational needs and decision making. J Psychosom Res. 2000;49:13-9.
53. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
54. Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O'shea N, Scher H, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47:340-7.
55. Van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot M-L. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer. Qual Life Res. 2009;18:1061-6.
56. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67:1063.
57. Rammstedt B, John OP. Measuring personality in one minute or less: a 10-item short version of the Big Five Inventory in English and German. J Res Pers. 2007;41:203-12.
58. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy. J Gen Intern Med. 1989;4:23-30.
59. Schwartz B, Ward A, Monterosso J, Lyubomirsky S, White K, Lehman DR. Maximizing versus satisficing: happiness is a matter of choice. J Pers Soc Psychol. 2002;83:1178.
60. Fleuren MA, Paulussen TG, Van Dommelen P, Van Buuren S. Towards a measurement instrument for determinants of innovations. Int J Qual Health Care. 2014;26:501-10.
61. Naylor CD, Llewellyn-Thomas HA. Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol. 1994;47:787-95.
62. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clin Trials. 2005;2:99-107.
63. Bell ML, McKenzie JE. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psychooncology. 2013;22:1738-47.
64. Schofield P, Lofti-Jam K, Gough K, Dudgeon P, Bergin R, Crellin W, et al. A nurse-led group consultation intervention to reduce psychological morbidity and unmet needs in men with prostate cancer during radiotherapy: a randomised controlled trial. New York City, USA: MASCC/ISOO International Symposium on Supportive Care in Cancer; 2012. p. 145.
65. Husson O, Thong MS, Mols F, Smilde TJ, Creemers G-J, van de Poll-Franse LV. Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry. J Palliat Med. 2013;16:281-8.
66. Husson O, Mols F, Oranje W, Haak H, Nieuwlaat W, Netea-Maier R, et al. Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry. Psychooncology. 2014;23:946-52.
67. Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J. Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst. 2008;100:483-91. doi:10.1093/jnci/djn066.
68. Nelson WL, Han PKJ, Fagerlin A, Stefanek M, Ubel PA. Rethinking the objectives of decision aids: a call for conceptual clarity. Med Decis Making. 2007;27:609-18. doi:10.1177/0272989x07306780.